BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7835227)

  • 1. Formation of toxic metabolites from thiabendazole and other thiazoles in mice. Identification of thioamides as ring cleavage products.
    Mizutani T; Yoshida K; Kawazoe S
    Drug Metab Dispos; 1994; 22(5):750-5. PubMed ID: 7835227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of thioformamide as a proximate toxicant in the nephrotoxicity of thiabendazole and related thiazoles in glutathione-depleted mice: structure-toxicity and metabolic studies.
    Mizutani T; Yoshida K; Kawazoe S
    Chem Res Toxicol; 1993; 6(2):174-9. PubMed ID: 8477008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo metabolism of epothilone B in tumor-bearing nude mice: identification of three new epothilone B metabolites by capillary high-pressure liquid chromatography/mass spectrometry/tandem mass spectrometry.
    Blum W; Aichholz R; Ramstein P; Kühnöl J; Brüggen J; O'Reilly T; Flörsheimer A
    Rapid Commun Mass Spectrom; 2001; 15(1):41-9. PubMed ID: 11135423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism and excretion of a new antipsychotic drug, ziprasidone, in humans.
    Prakash C; Kamel A; Gummerus J; Wilner K
    Drug Metab Dispos; 1997 Jul; 25(7):863-72. PubMed ID: 9224781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The rabbit liver microsomal biotransformation of 1,1-dialkylethylenes: enantioface selection of epoxidation and enantioselectivity of epoxide hydrolysis.
    Bellucci G; Chiappe C; Cordoni A; Marioni F
    Chirality; 1994; 6(3):207-12. PubMed ID: 8024951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism of an atypical antipsychotic agent, 3-[4-[4-(6-fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2, 5,5-trimethyl-4-thiazolidinone (HP236).
    Mutlib AE; Jurcak J; Hrib N
    Drug Metab Dispos; 1996 Oct; 24(10):1139-50. PubMed ID: 8894517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotransformation of 12C- and 2-13C-labeled methyl tert-butyl ether, ethyl tert-butyl ether, and tert-butyl alcohol in rats: identification of metabolites in urine by 13C nuclear magnetic resonance and gas chromatography/mass spectrometry.
    Bernauer U; Amberg A; Scheutzow D; Dekant W
    Chem Res Toxicol; 1998 Jun; 11(6):651-8. PubMed ID: 9625733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative hepatotoxicity of 2-(substituted phenyl)thiazoles and substituted thiobenzamides in mice: evidence for the involvement of thiobenzamides as ring cleavage metabolites in the hepatotoxicity of 2-phenylthiazoles.
    Mizutani T; Suzuki K
    Toxicol Lett; 1996 May; 85(2):101-5. PubMed ID: 8650692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo biotransformation of 17 alpha-methyltestosterone in the horse revisited: identification of 17-hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry.
    Dumasia MC
    Rapid Commun Mass Spectrom; 2003; 17(4):320-9. PubMed ID: 12569442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).
    Nicoll-Griffith DA; Chauret N; Yergey JA; Trimble LA; Favreau L; Zamboni R; Grossman SJ; Drey J; Herold E
    Drug Metab Dispos; 1993; 21(5):861-7. PubMed ID: 7902249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous determination of MK-0767 and seven metabolites in rat urine using liquid chromatography/tandem mass spectrometry.
    Shen Z; Kochansky C; Bakhtiar R; Franklin RB; Vincent SH
    Rapid Commun Mass Spectrom; 2004; 18(18):2113-20. PubMed ID: 15317046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biliary excretion of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) and metabolites by Fischer 344 rats.
    Musser SM; Egorin MJ; Zuhowski EG; Hamburger DR; Parise RA; Covey JM; White KD; Eiseman JL
    Cancer Chemother Pharmacol; 2003 Aug; 52(2):139-46. PubMed ID: 12761648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gas chromatographic/mass spectrometric analysis of oxo and chain-shortened leukotriene B4 metabolites. Leukotriene B4 metabolism in Ito cells.
    Wheelan P; Murphy RC; Simon FR
    J Mass Spectrom; 1996 Mar; 31(3):236-46. PubMed ID: 8799275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of the in vivo liver metabolites of (--)-delta 7-tetrahydrocannabinol produced by the mouse.
    Harvey DJ; Gill EW; Slater M; Paton WD
    Drug Metab Dispos; 1980; 8(6):439-45. PubMed ID: 6109613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P-450-dependent bioactivation of 1,1-dichloroethylene to a reactive epoxide in human lung and liver microsomes.
    Dowsley TF; Reid K; Petsikas D; Ulreich JB; Fisher RL; Forkert PG
    J Pharmacol Exp Ther; 1999 May; 289(2):641-8. PubMed ID: 10215634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the novel benzisothiazole ring-cleaved products of the antipsychotic drug ziprasidone.
    Prakash C; Kamel A; Cui D
    Drug Metab Dispos; 1997 Jul; 25(7):897-901. PubMed ID: 9224786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of in vivo liver metabolites of delta 6-tetrahydrocannabinol produced by the mouse.
    Harvey DJ; Paton WD
    Drug Metab Dispos; 1980; 8(3):178-86. PubMed ID: 6104583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mass spectrometry of 2-substituted-4-arylthiazoles. II--Identification of microsomal nitroreduction product by mass spectrometry.
    Mattammal MB; Zenser TV; Davis BB
    Biomed Mass Spectrom; 1982 Sep; 9(9):376-80. PubMed ID: 7139057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mass spectrometry of 2-substituted-4-arylthiazoles. 3--Identification of microsomal nitroreduction products by mass spectrometry.
    Mattammal MB; Zenser TV; Davis BB; White EV
    Biomed Mass Spectrom; 1984 Apr; 11(4):149-54. PubMed ID: 6733253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.
    Kalgutkar AS; Driscoll J; Zhao SX; Walker GS; Shepard RM; Soglia JR; Atherton J; Yu L; Mutlib AE; Munchhof MJ; Reiter LA; Jones CS; Doty JL; Trevena KA; Shaffer CL; Ripp SL
    Chem Res Toxicol; 2007 Dec; 20(12):1954-65. PubMed ID: 17935300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.